AEPCX
Price
$62.77
Change
+$0.52 (+0.84%)
Updated
Oct 3 closing price
Net Assets
138.77B
PWJAX
Price
$35.86
Change
+$0.10 (+0.28%)
Updated
Oct 3 closing price
Net Assets
5.69B
Interact to see
Advertisement

AEPCX vs PWJAX

Header iconAEPCX vs PWJAX Comparison
Open Charts AEPCX vs PWJAXBanner chart's image
American Funds EUPAC C
Price$62.77
Change+$0.52 (+0.84%)
VolumeN/A
Net Assets138.77B
PGIM Jennison International Opps A
Price$35.86
Change+$0.10 (+0.28%)
VolumeN/A
Net Assets5.69B
AEPCX vs PWJAX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. PWJAX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and PWJAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 139B vs. PWJAX (5.69B). AEPCX pays higher dividends than PWJAX: AEPCX (0.16) vs PWJAX (0.00). AEPCX was incepted earlier than PWJAX: AEPCX (25 years) vs PWJAX (13 years). AEPCX (1.57) is less costly to investors than PWJAX (1.24). PWJAX is a more actively managed with annual turnover of: 44.00 vs. AEPCX (35.00). AEPCX has a lower initial minimum investment than PWJAX: AEPCX (250) vs PWJAX (1000). PWJAX annual gain was more profitable for investors over the last year : 15.12 vs. AEPCX (10.37). PWJAX return over 5 years is better than : 27.98 vs. AEPCX (13.86).
AEPCXPWJAXAEPCX / PWJAX
Total Expense Ratio1.571.09144%
Annual Report Gross Expense Ratio1.571.24127%
Fund Existence25 years13 years-
Gain YTD21.48220.863103%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets139B5.69B2,445%
Annual Yield % from dividends0.160.00-
Returns for 1 year10.3715.1269%
Returns for 3 years42.8258.3973%
Returns for 5 years13.8627.9850%
Returns for 10 years39.95184.6022%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TVRD40.232.86
+7.65%
Tvardi Therapeutics Inc
OACCU10.65N/A
N/A
Oaktree Acquisition Corp III Life Sciences
GNTA3.30-0.01
-0.25%
Genenta Science SpA
IMCR34.21-1.08
-3.06%
Immunocore Holdings plc
IDCC339.10-17.00
-4.77%
InterDigital